Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

594
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
594
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indigenous knowledge and modern science: a comprehensive review of phytochemicals in <i>Panax ginseng</i> flower for nutritional and health applications.

Frontiers in nutrition·2026
Same author

Engineered Neutrophils in Translational Medicine: Gene Editing, Nanotechnology, and AI-Driven Clinical Breakthroughs.

Advanced healthcare materials·2026
Same author

NSUN2/m5C/TPI1 axis promotes glycolysis and immune evasion in breast cancer.

Journal of translational medicine·2026
Same author

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Cancers·2026
Same author

Photoinduced Radical Alkylation of Cyclic Aldimines with Unactivated C(sp<sup>3</sup>)-H Alcohols Enabled by Alcohol-Directed 1,5-Hydrogen Atom Transfer.

The Journal of organic chemistry·2026
Same author

Implications of LINC01094 for human malignancies.

PeerJ·2026

Related Experiment Video

Updated: Dec 28, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

GWAS in cancer: progress and challenges.

Baiqiang Liang1,2,3, Hongrong Ding2,4, Lianfang Huang1,2

  • 1Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, 524023, China.

Molecular Genetics and Genomics : MGG
|February 13, 2020
PubMed
Summary

Genome-wide association studies (GWAS) identify genetic variations linked to diseases. This review categorizes new tumor-related findings, revealing how susceptible sites, including hub and peripheral genes, interact to influence gene expression in various cancers.

Keywords:
CancerGWASGenotypeReviewSNPsSusceptible gene

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

755
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.6K

Related Experiment Videos

Last Updated: Dec 28, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

755
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.6K

Area of Science:

  • Genomics and Cancer Research
  • Genetic Epidemiology
  • Molecular Biology

Background:

  • Genome-wide association studies (GWAS) are crucial for identifying single-nucleotide polymorphisms (SNPs) associated with complex diseases.
  • While GWAS has identified numerous loci for complex phenotypes, their biological functions and underlying genetic mechanisms in diseases, particularly tumors, remain largely unexplained.
  • Existing literature shows increasing application of GWAS in cancer research, highlighting the need for systematic review and categorization of findings.

Purpose of the Study:

  • To review and categorize recent findings from GWAS in various tumor types.
  • To elucidate the mechanisms of action for newly discovered genetic variation loci in cancer.
  • To explore the links between identified genetic mechanisms and gene expression pathways across different cancers.

Main Methods:

  • Systematic review of recent literature on GWAS applied to tumor studies.
  • Categorization of newly discovered genetic sites and their associated mechanisms.
  • Analysis of gene expression pathways and their linkage to identified susceptible sites.

Main Results:

  • Identification and categorization of novel genetic loci and mechanisms associated with various tumor types.
  • Demonstration of interactions between susceptible sites, classified as hub genes and peripheral genes.
  • Established links between these gene interactions and altered gene expression pathways relevant to cancer development.

Conclusions:

  • Recent GWAS findings offer new insights into the genetic architecture of various cancers.
  • Susceptible sites in cancer can be functionally categorized into interacting hub and peripheral genes.
  • Understanding these gene interactions and pathways is key to deciphering the genetic mechanisms of complex diseases like cancer.